VRCA · Verrica Pharmaceuticals Inc.
$4.97
+0.11 (+2.26%)
At close · Aug 14
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that substantial doubt exists regarding its ability to continue as a going concern within one year after the date these consolidated financial statements are issued.”View the 10-Q filed Aug 6, 2026
Market Cap
$87.44M
Shares
17.18M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Christopher G. Hayes | Former Chief Legal Officer | $747,579 |
| Jayson Rieger | President and Chief Executive Officer | $741,403 |
| John Kirby | Interim Chief Financial Officer | $614,600 |
| Gary Goldenberg | Former Chief Medical Officer | $363,127 |
| Noah Rosenberg | Chief Medical Officer | $347,588 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $2,594,832 |
| Joe Bonaccorso | Former Chief Commercial Officer | $1,279,038 |
| Jayson Rieger | President and Chief Executive Officer | $1,236,225 |
| Christopher G. Hayes | Chief Legal Officer | $1,028,062 |
| Gary Goldenberg | Former Chief Medical Officer | $973,317 |
| John Kirby | Interim Chief Financial Officer | $114,587 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ted White | Former President and Chief Executive Officer | $3,504,647 |
| Christopher G. Hayes | Chief Legal Officer | $2,561,674 |
| Joe Bonaccorso | Former Chief Commercial Officer | $2,097,472 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,935,834 |
| Joe Bonaccorso | Chief Commercial Officer | $986,518 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joe Bonaccorso | Chief Commercial Officer | $1,224,333 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,706,704 |
| Gary Goldenberg | Chief Medical Officer | $1,514,036 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Ted White | President, Chief Executive Officer and Director | $1,441,189 |
| A. Brian Davis | Chief FinancialOfficer | $1,339,581 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lawrence Eichenfield | director | Appointed | 2026-06-09 |
| Paul B. Manning | director | Appointed | 2026-06-09 |
| Charles Frantzreb | director | Appointed | 2025-12-30 |
| Christopher G. Hayes | Chief Legal Officer, Chief Compliance Officer and Corporate Secretary | Resigned | 2025-04-25 |
| Gavin Corcoran | director | Appointed | 2025-04-02 |
| David Zawitz | Chief Operating Officer and principal operating officer | Appointed | 2024-12-09 |
| Jayson Rieger | member of the Board | Appointed | 2024-11-04 |
| Jayson Rieger | President, Chief Executive Officer | Appointed | 2024-11-04 |
| Ted White | member of the Company's Board of Directors | Resigned | 2024-11-04 |
| Ted White | President and Chief Executive Officer | Resigned | 2024-11-04 |
| Diem Nguyen | member of the Audit Committee of the Board | Appointed | 2024-10-08 |
| Craig Ballaron | member of the Board of Directors | Resigned | 2024-10-08 |
| Terence Kohler | Chief Financial Officer | Resigned | 2024-09-27 |
| Joe Bonaccorso | Chief Commercial Officer | Resigned | 2024-08-27 |
Key facts
CIK
1660334
CUSIP
92511W207
13F (30d)
42 filings
42 filers
Visit website
Investor relations